BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 2065288)

  • 1. Avascular necrosis of bone in children undergoing allogeneic bone marrow transplantation.
    Mascarin M; Giavitto M; Zanazzo GA; Andolina M; Cova M; Accorsi E; Tamaro P
    Cancer; 1991 Aug; 68(3):655-9. PubMed ID: 2065288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Avascular necrosis of bone after allogeneic bone marrow transplantation: clinical findings, incidence and risk factors.
    Socié G; Sélimi F; Sedel L; Frija J; Devergie A; Esperou Bourdeau H; Ribaud P; Gluckman E
    Br J Haematol; 1994 Mar; 86(3):624-8. PubMed ID: 8043445
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Avascular necrosis of bone: a common serious complication of allogeneic bone marrow transplantation.
    Enright H; Haake R; Weisdorf D
    Am J Med; 1990 Dec; 89(6):733-8. PubMed ID: 2252042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Etoposide, cyclophosphamide, total-body irradiation, and allogeneic bone marrow transplantation for hematologic malignancies.
    Giralt SA; LeMaistre CF; Vriesendorp HM; Andersson BS; Dimopoulos M; Gajewski J; Van Besien K; Mehra R; Przepiorka D; Khouri I
    J Clin Oncol; 1994 Sep; 12(9):1923-30. PubMed ID: 8083714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Allogeneic bone marrow transplantation for children with acute leukemia: cytoreduction with fractionated total body irradiation, high-dose etoposide and cyclophosphamide.
    Duerst RE; Horan JT; Liesveld JL; Abboud CN; Zwetsch LM; Senf ES; Constine LS; Raubertas RF; Passarell JA; DiPersio JF
    Bone Marrow Transplant; 2000 Mar; 25(5):489-94. PubMed ID: 10713624
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Avascular necrosis of bone in children with leukemia: experience of pediatric hematology unit in kuwait.
    Bourisly MJ; Al-Mazidi Z; Saleh H; Bourhama M; Al-Matter E
    Gulf J Oncolog; 2010 Jul; (8):48-51. PubMed ID: 20601340
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of total body irradiation as based on the comparison of preparation regimens for allogeneic bone marrow transplantation for acute leukemia in first complete remission.
    Inoue T; Ikeda H; Yamazaki H; Tang JT; Song C; Teshima T; Murayama S; Ohtani M; Shibata H; Masaoka T
    Strahlenther Onkol; 1993 Apr; 169(4):250-5. PubMed ID: 8488461
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractionated total-body irradiation, etoposide, and cyclophosphamide followed by allogeneic bone marrow transplantation for patients with high-risk or advanced-stage hematological malignancies.
    Long GD; Amylon MD; Stockerl-Goldstein KE; Negrin RS; Chao NJ; Hu WW; Nademanee AP; Snyder DS; Hoppe RT; Vora N; Wong R; Niland J; Reichardt VL; Forman SJ; Blume KG
    Biol Blood Marrow Transplant; 1997 Dec; 3(6):324-30. PubMed ID: 9502300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allogeneic bone marrow transplantation for childhood acute lymphoblastic leukemia in second remission: factors predictive of survival, relapse and graft-versus-host disease.
    Moussalem M; Esperou Bourdeau H; Devergie A; Baruchel A; Ribaud P; Socie G; Parquet N; Traineau R; Hirsch I; Schaison G
    Bone Marrow Transplant; 1995 Jun; 15(6):943-7. PubMed ID: 7581095
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal toxicity after allogeneic bone marrow transplantation: the combined effects of total-body irradiation and graft-versus-host disease.
    Miralbell R; Bieri S; Mermillod B; Helg C; Sancho G; Pastoors B; Keller A; Kurtz JM; Chapuis B
    J Clin Oncol; 1996 Feb; 14(2):579-85. PubMed ID: 8636774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Avascular necrosis in long-term survivors after allogeneic or autologous stem cell transplantation: a single center experience and a review.
    Tauchmanovà L; De Rosa G; Serio B; Fazioli F; Mainolfi C; Lombardi G; Colao A; Salvatore M; Rotoli B; Selleri C
    Cancer; 2003 May; 97(10):2453-61. PubMed ID: 12733144
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD6+ donor marrow T-cell depletion as the sole form of graft-versus-host disease prophylaxis in patients undergoing allogeneic bone marrow transplant from unrelated donors.
    Soiffer RJ; Weller E; Alyea EP; Mauch P; Webb IL; Fisher DC; Freedman AS; Schlossman RL; Gribben J; Lee S; Anderson KC; Marcus K; Stone RM; Antin JH; Ritz J
    J Clin Oncol; 2001 Feb; 19(4):1152-9. PubMed ID: 11181681
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Avascular necrosis of bone following combination chemotherapy for acute lymphocytic leukemia.
    Felix C; Blatt J; Goodman MA; Medina J
    Med Pediatr Oncol; 1985; 13(5):269-72. PubMed ID: 3861932
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Long-term follow-up of patients undergoing allogeneic bone marrow transplantation for acute myeloid leukemia in first complete remission after cyclophosphamide-total body irradiation and cyclosporine.
    Mehta J; Powles R; Treleaven J; Horton C; Tait D; Meller S; Pinkerton CR; Middleton G; Eisen T; Singhal S
    Bone Marrow Transplant; 1996 Oct; 18(4):741-6. PubMed ID: 8899189
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Total body irradiation, thiotepa, and cyclophosphamide as a conditioning regimen for children with acute lymphoblastic leukemia in first or second remission undergoing bone marrow transplantation with HLA-identical siblings.
    Zecca M; Pession A; Messina C; Bonetti F; Favre C; Prete A; Cesaro S; Porta F; Mazzarino I; Giorgiani G; Rondelli R; Locatelli F
    J Clin Oncol; 1999 Jun; 17(6):1838-46. PubMed ID: 10561223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Unrelated allogeneic bone marrow transplantation using high-dose busulfan and cyclophosphamide (BU-CY) for the preparative regimen.
    Sahebi F; Copelan E; Crilley P; Bolwell B; Avalos B; Klein J; Territo M; Gajewski J
    Bone Marrow Transplant; 1996 May; 17(5):685-9. PubMed ID: 8733682
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chemotherapy versus allogeneic bone marrow transplantation in adults with acute lymphoblastic leukemia.
    Mrsić M; Nemet D; Labar B; Bogdanić V; Radman I; Zupancić-Salek S; Kovacević-Metelko J; Aurer I; Maravić N
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1268-70. PubMed ID: 8442109
    [No Abstract]   [Full Text] [Related]  

  • 18. Avascular necrosis of bone following allogeneic stem cell transplantation: MR screening and therapeutic options.
    Wiesmann A; Pereira P; Böhm P; Faul C; Kanz L; Einsele H
    Bone Marrow Transplant; 1998 Sep; 22(6):565-9. PubMed ID: 9758344
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High-dose cytosine arabinoside and fractionated total body irradiation as a preparative regimen for the treatment of children with acute lymphoblastic leukemia and Down syndrome by allogeneic bone marrow transplantation.
    Conter V; D'Angelo P; Rizzari C; Jankovic M; Dampier C; Masera G; Johnson FL
    Bone Marrow Transplant; 1996 Feb; 17(2):287-9. PubMed ID: 8640182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Chemotherapy for induction of remission of childhood acute myeloid leukemia followed by marrow transplantation or multiagent chemotherapy: a report from the Childrens Cancer Group.
    Nesbit ME; Buckley JD; Feig SA; Anderson JR; Lampkin B; Bernstein ID; Kim TH; Piomelli S; Kersey JH; Coccia PF
    J Clin Oncol; 1994 Jan; 12(1):127-35. PubMed ID: 8270968
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.